These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24468315)

  • 81. Intraocular Relapse with Hypopyon and Retinal Infiltrates after Chemotherapy and Peripheral Blood Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma.
    Matsuo T; Tanaka T; Ichimura K; Meguri Y
    J Clin Exp Hematop; 2015; 55(3):157-61. PubMed ID: 26763364
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].
    Chen F; Shen CX; Wang HG; Li GX; Wang XQ; Wen Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):327-333. PubMed ID: 29871255
    [No Abstract]   [Full Text] [Related]  

  • 83. Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.
    Tachita T; Takahata T; Yamashita S; Ebina T; Kamata K; Yamagata K; Tamai Y; Sakuraba H
    Int J Hematol; 2023 Oct; 118(4):503-507. PubMed ID: 37093551
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Recent advances on extranodal NK/T-cell lymphoma of nasal type].
    Wang TT; Wang Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1624-8. PubMed ID: 20030961
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
    Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Extranodal NK/T Cell Lymphoma: Evidence-based Review of Safety and Toxicity of the Available Regimens.
    Saeed H; Sokol L
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):199-204. PubMed ID: 33129745
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.
    Dong LH; Zhang LJ; Wang WJ; Lei W; Sun X; Du JW; Gao X; Li GP; Li YF
    Leuk Lymphoma; 2016 Jul; 57(7):1600-6. PubMed ID: 26726970
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma.
    Xiang-Lan M; Zu-Lan S; Dan H; Bi-Hong S; Ya-Qin P; Han-Liang L
    Transl Res; 2008 Jun; 151(6):303-8. PubMed ID: 18514141
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Extranodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous breast involvement].
    Fréling E; Granel-Brocard F; Serrier C; Ortonne N; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2015 Feb; 142(2):104-11. PubMed ID: 25554664
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].
    Yao N; Cui X; Wang J
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):106-10. PubMed ID: 25907839
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
    Wang J; Wei L; Ye J; Yang L; Li X; Cong J; Yao N; Cui X; Wu Y; Ding J; Zhang L
    Int J Hematol; 2018 Jan; 107(1):98-104. PubMed ID: 28856590
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
    Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
    J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.
    Huang L; Yuan B; Wu H; Chu H; Liu Y; Wu S; Li H; Lu H; Chen H
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):152-158. PubMed ID: 28215935
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
    Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
    Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 96. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.
    Jiang M; Zhang L; Xie L; Zhang H; Jiang Y; Liu WP; Zhang WY; Tian R; Deng YT; Zhao S; Zou LQ
    Oncotarget; 2017 Jul; 8(30):50155-50163. PubMed ID: 28404973
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
    Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
    Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
    Kim M; Kim TM; Kim KH; Keam B; Lee SH; Kim DW; Lee JS; Jeon YK; Kim CW; Heo DS
    Ann Hematol; 2015 Mar; 94(3):437-44. PubMed ID: 25300500
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management].
    Dağoğlu RN; Ozdemir O; Ergen A; Ağaoğlu FY
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(3):164-71. PubMed ID: 22663927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.